Mizuho Forecasts Strong Price Appreciation for Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price target increased by Mizuho from $20.00 to $41.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Mizuho’s price target points to a potential upside of 1.51% from the company’s current price. Other equities research analysts have [...]